| Alice Yu, | |
|
12902 Usf Magnolia Dr, Tampa, FL 33612-9416 | |
| (813) 745-2226 | |
| Not Available |
| Full Name | Alice Yu |
|---|---|
| Gender | Female |
| Speciality | Urology |
| Experience | 11 Years |
| Location | 12902 Usf Magnolia Dr, Tampa, Florida |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013496843 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 277590 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| H Lee Moffitt Cancer Ctr And Res Inst Life Time Cancer Scrn Ctr Inc | 2264337021 | 920 |
News Archive
A propensity for attention deficit hyperactivity disorder (ADHD) might be beneficial to a group of Kenyan nomads, according to new research published in the open access journal BMC Evolutionary Biology.
Sunquest Information Systems, Inc., a market leader in laboratory and diagnostic information systems, the Massachusetts General Hospital (MGH), an innovator in medical care, research and teaching, and Partners HealthCare System, an integrated health care delivery system with a tradition of IT excellence, today announced a collaborative agreement to jointly develop the next generation anatomic and clinical pathology based laboratory information system.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
The overall vaccination rate among black children ages 19 months to 35 months last year for the first time equaled rates among white, Asian and Hispanic children in the same age group, according to a CDC report released recently, the AP/Seattle Post-Intelligencer reports.
Glioblastomas are relentless, hard-to-treat, and often lethal brain tumors. Yale scientists have enlisted a most unlikely ally in efforts to treat this form of cancer - elements of the Ebola virus.
› Verified 7 days ago
| Entity Name | H Lee Moffitt Cancer Ctr & Res Inst Life Time Cancer Scrn Ctr Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1306833595 PECOS PAC ID: 2264337021 Enrollment ID: O20031204000575 |
News Archive
A propensity for attention deficit hyperactivity disorder (ADHD) might be beneficial to a group of Kenyan nomads, according to new research published in the open access journal BMC Evolutionary Biology.
Sunquest Information Systems, Inc., a market leader in laboratory and diagnostic information systems, the Massachusetts General Hospital (MGH), an innovator in medical care, research and teaching, and Partners HealthCare System, an integrated health care delivery system with a tradition of IT excellence, today announced a collaborative agreement to jointly develop the next generation anatomic and clinical pathology based laboratory information system.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
The overall vaccination rate among black children ages 19 months to 35 months last year for the first time equaled rates among white, Asian and Hispanic children in the same age group, according to a CDC report released recently, the AP/Seattle Post-Intelligencer reports.
Glioblastomas are relentless, hard-to-treat, and often lethal brain tumors. Yale scientists have enlisted a most unlikely ally in efforts to treat this form of cancer - elements of the Ebola virus.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Alice Yu, 12902 Usf Magnolia Dr, Tampa, FL 33612-9416 Ph: (813) 745-2226 | Alice Yu, 12902 Usf Magnolia Dr, Tampa, FL 33612-9416 Ph: (813) 745-2226 |
News Archive
A propensity for attention deficit hyperactivity disorder (ADHD) might be beneficial to a group of Kenyan nomads, according to new research published in the open access journal BMC Evolutionary Biology.
Sunquest Information Systems, Inc., a market leader in laboratory and diagnostic information systems, the Massachusetts General Hospital (MGH), an innovator in medical care, research and teaching, and Partners HealthCare System, an integrated health care delivery system with a tradition of IT excellence, today announced a collaborative agreement to jointly develop the next generation anatomic and clinical pathology based laboratory information system.
Living Cell Technologies Limited, a company pioneering the development of a cell implant to treat diabetes, has obtained approval to commence a Phase II DIABECELL clinical trial in Buenos Aires, Argentina, DIABECELL's third jurisdiction to date which has approved human trials. Up to eight adult patients with Type 1 diabetes, including those with unstable diabetes and severe hypoglycaemia, will each receive two implants of DIABECELL, three months apart with a dose seeking component. The trial is expected to begin in the second half of this year.
The overall vaccination rate among black children ages 19 months to 35 months last year for the first time equaled rates among white, Asian and Hispanic children in the same age group, according to a CDC report released recently, the AP/Seattle Post-Intelligencer reports.
Glioblastomas are relentless, hard-to-treat, and often lethal brain tumors. Yale scientists have enlisted a most unlikely ally in efforts to treat this form of cancer - elements of the Ebola virus.
› Verified 7 days ago
Alberto Juan Duboy, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 12901 Bruce B Downs Blvd, Mdc 41, Tampa, FL 33612 Phone: 813-259-8581 Fax: 813-259-8507 | |
Mohit Sirohi, MD Urology Medicare: Accepting Medicare Assignments Practice Location: 1 Davis Blvd., #604, Tampa, FL 33606 Phone: 813-258-9565 Fax: 813-258-3535 | |
Dr. Mohendra Gopal Biswas, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 6101 Webb Rd, Suite 203, Tampa, FL 33615 Phone: 813-884-4794 Fax: 813-882-0650 | |
Dr. Jeffrey Bernard Starling, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 5332 Primrose Lake Cir, Tampa, FL 33647 Phone: 813-558-9091 Fax: 813-866-3948 | |
Dr. Fernando E. Coste-delvecchio, M.D. Urology Medicare: Accepting Medicare Assignments Practice Location: 2 Tampa General Cir, Stc 7th Floor, Tampa, FL 33606 Phone: 813-974-4115 | |
Elliot Michael Reisman, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 4712 N Armenia Ave, Suite 200, Tampa, FL 33603 Phone: 813-874-7400 Fax: 813-877-1397 |